Allakos (ALLK)
(Delayed Data from NSDQ)
$0.66 USD
-0.04 (-5.40%)
Updated Aug 9, 2024 04:00 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Allakos Inc. (ALLK) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$2.77 | $7.00 | $0.85 | 319.70% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Allakos Inc. comes to $2.77. The forecasts range from a low of $0.85 to a high of $7.00. The average price target represents an increase of 319.7% from the last closing price of $0.66.
Analyst Price Targets (5 )
Broker Rating
Allakos Inc. currently has an average brokerage recommendation (ABR) of 2.56 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 2.56 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, three are Strong Buy, representing 33.33% of all recommendations. A month ago, Strong Buy represented 33.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.56 | 2.56 | 2.56 | 2.56 | 2.56 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/26/2024 | JMP Securities | Jonathan Wolleben | Strong Buy | Strong Buy |
6/20/2024 | Cantor Fitzgerald & Co | Jennifer Kim | Hold | Hold |
5/10/2024 | William Blair | Timothy F Lugo | Strong Buy | Strong Buy |
5/10/2024 | Piper Sandler | Yasmeen Rahimi | Strong Buy | Strong Buy |
5/10/2024 | Not Identified | Not Identified | Strong Sell | Strong Sell |
5/10/2024 | LifeSci Capital | Sam Slutsky | Hold | Hold |
4/1/2024 | Cowen & Co. | Joseph Thome | Hold | Hold |
12/1/2023 | SVB Securities | Thomas J Smith | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.56 |
ABR (Last week) | 2.56 |
# of Recs in ABR | 9 |
Average Target Price | $2.77 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 75 of 253 |
Current Quarter EPS Est: | -0.23 |